Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06194578 · ClinicalTrials.gov registry record · Early Phase 1

A Study of Sterile Saline Infusion in Healthy Volunteers

A Early Phase 1 study, sponsored by Janssen Research & Development.

Completed
Registry status
Early Phase 1
Development phase
32
Enrollment target

NCT06194578: Completed Early Phase 1 study, sponsored by Janssen Research & Development.

NCT06194578 is a Early Phase 1 study that has completed, run by Janssen Research & Development. The registered enrollment target is 32 participants, below the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (40% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06194578, a Early Phase 1 study, has completed, sponsored by Janssen Research & Development.

COMPLETED
Registry status
Early Phase 1
Development phase
32 participants
Enrollment target

Study Summary

The purpose of the study is to evaluate the influence of needle size, injected fluid volume, and rate of fluid on the degree of pain experienced by adult healthy volunteers after subcutaneous infusion of sterile saline.

Primary Outcome

Participant's pain intensity during or after the saline infusion as assessed by VAS score will be reported. VAS is a self-reported pain rating scale ranging 0=no pain to 100=worst possible pain.

Interventions

  • OTHER Sterile Saline

Trial Details

FieldValue
Enrollment Target 32 participants
Start Date 2024-01-12
Est. Completion 2024-04-23
Phase Early Phase 1
Janssen Research & Development

593 total trials

What the finished NCT06194578 record still lists

NCT06194578 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 32 participants, a relatively small participant target, below the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (40% lower).

The record links to 0 conditions, and to 1 intervention - of which Sterile Saline is the first listed.

NCT06194578 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT06194578 about?

NCT06194578 is a clinical study titled "A Study of Sterile Saline Infusion in Healthy Volunteers". The purpose of the study is to evaluate the influence of needle size, injected fluid volume, and rate of fluid on the degree of pain experienced by adult healthy volunteers after subcutaneous infusion of sterile saline.

What is the current status of trial NCT06194578?

This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 32 participants. The study started on 2024-01-12. Estimated completion is 2024-04-23.

What interventions are being tested in trial NCT06194578?

The interventions under investigation include: Sterile Saline (OTHER).

Who is sponsoring clinical trial NCT06194578?

This trial is sponsored by Janssen Research & Development, which has 593 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT06194578's enrollment target sits among peer trials

32 775th of 2000 higher than 1,208 of 2,000 other Early Phase 1 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Early Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02445781 · 32 participants · Early Phase 1

    Differing Levels of Hypoglycemia

  • NCT02792270 · 32 participants · NA

    Caloric Restriction In Sarcoma Patients Treated With Pre-Operative RT

  • NCT03068910 · 32 participants · Early Phase 1

    Hyperandrogenemia and Altered Day-night LH Pulse Patterns

  • NCT03208868 · 32 participants · NA

    Leucine Enriched Essential Amino Acid Mixture to Reverse Muscle Loss in Cirrhosis

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06194578, the US trial registry maintained by the National Library of Medicine. NCT06194578 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.